Oxford trio set to make £150m with biotech business
Biotech firm Oxford Nanopore will list its shares later this year. It is valued at about £2.3 billion by a top investor and analysts believe its value could easily top £4 billion. The scientists who founded it, Gordon Sanghera, 60, Hagan Bayley, 70, and Spike Willcocks, 44, and their families could pocket as much as £150 million between them. Their company specialises in DNA sequencing and has developed a pocket-sized device which could revolutionise healthcare. The company’s technology has helped to sequence the virus that causes Covid-19 and during the pandemic has been used ...